Maxcort 6 Tablet

About Maxcort 6 Tablet

Maxcort 6 comes as a tablet with 6 mg of Deflazacort, from Novatek Pharmaceuticals Ltd. Not every patient with these conditions should receive it, and the doctor decides whether it is suitable and how long it should be used.

There are 28 brands of Deflazacort listed in Bangladesh. The lowest listed price is Dezert 6 mg Tablet at ৳ 8.00 per unit.

What is Maxcort 6 Tablet?

Maxcort 6 is a tablet from Novatek Pharmaceuticals Ltd., with the generic name Deflazacort. It works by blocking an enzyme involved in inflammation and by reducing the release of immune system chemicals. Because Deflazacort affects many body systems, it is important to use it exactly as prescribed and to tell your doctor about other medicines you take. The dose and length of treatment are set by your doctor based on your condition.

Uses of Maxcort 6

Not every patient with these conditions should receive it, and the doctor decides whether it is suitable and how long it should be used. It may also be used in other conditions where a corticosteroid is needed. Maxcort 6 is used in adults and some children for conditions where inflammation or immune activity needs to be controlled. The doctor decides whether it suits a particular person and what the treatment plan should be.

How to use Maxcort 6

Swallow the tablet as directed and do not stop it suddenly unless the doctor says so. Maxcort 6 is taken by mouth. Swallow the tablet with water. If you miss a dose, ask your doctor or pharmacist what to do rather than doubling up. The dose and duration depend on your condition and will be determined by your doctor.

Side effects of Maxcort 6

Call the doctor if you see signs of infection, severe stomach pain, unusual weight gain, swelling, or changes in vision. Some people have allergic reactions. Like other glucocorticoids, Maxcort 6 can cause unwanted effects. Tell your doctor if you experience any unusual symptoms while taking this medicine.

Safety and precautions

It should not be used if you are allergic to any ingredient or are receiving live vaccines. Maxcort 6 is a glucocorticoid and should only be used under a doctor's supervision. Corticosteroids may affect the baby, so the doctor will weigh the benefits and risks. Ask your doctor before starting if you have any long-term health condition or take other medicines.

Frequently asked questions

What does Maxcort 6 treat?

Not every patient with these conditions should receive it, and the doctor decides whether it is suitable and how long it should be used. It may also be used in other conditions where a corticosteroid is needed.

How is Maxcort 6 used?

Swallow the tablet as directed and do not stop it suddenly unless the doctor says so. Maxcort 6 is taken by mouth.

What should I watch for while using Maxcort 6?

Call the doctor if you see signs of infection, severe stomach pain, unusual weight gain, swelling, or changes in vision. Some people have allergic reactions.

Can I use Maxcort 6 in pregnancy or while breastfeeding?

It should not be used if you are allergic to any ingredient or are receiving live vaccines. Maxcort 6 is a glucocorticoid and should only be used under a doctor's supervision.

Indications

Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • ... Read more
Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • Pemphigus,bullous pemphigoid, pyoderma gangrenosum
  • Minimal change nephrotic syndrome, acute interstitial nephritis
  • Rheumatic carditis
  • Ulcerative colitis, Crohn's disease
  • Uveitis, optic neuritis
  • Autoimmune haemolytic anaemia, idiopathic thrombocytopenic purpura
  • Acute and lymphatic leukaemia, malignant lymphoma, multiple myeloma
  • Immune suppression in transplantation

Pharmacology

Deflazacort provides anti-inflammatory action by inhibiting Phospholipase A2 enzyme which is responsible for prostaglandin synthesis. Besides Deflazacort decreases the release of certain chemicals that are important in the immune system. By decreasing the release of these chemicals Deflazacort provides immunosuppressive action.

Dosage & Administration

Adults-
  • For acute disorders: Up to 120 mg/day Deflazacort may need to be given initially. Maintenance doses in most conditions are within the range of 3-18 mg/day.
  • Rheumatoid arthritis: The maintenance dose is usually within the range of 3-18 mg/day. The smallest effective dose should be used and increased if necessary.
  • Bronchial asthma: In the treatment of an acute attack, high doses of 48-72 mg/day may be needed depending on severity and gradually reduced once the attack has been controlled. For maintenance in chronic asthma, doses should be titrated to the lowest dose that controls symptoms.
  • Other conditions: The dose of Deflazacort depends on clinical need titrated to the lowest effective dose for maintenance. Starting doses may be estimated on the basis of ratio of 5 mg prednisone or prednisolone to 6 mg.
Children: There has been limited exposure of children to Deflazacort in clinical trials. In children, the indications for glucocorticoids arethe same as for adults, but it is important that the lowest effective dosage is used. Alternate day administration may be appropriate. Doses of Deflazacort usually lie in the range 0.25-1.5 mg/kg/day.

The following ranges provide general guidance:
  • Juvenile chronic arthritis: The usual maintenance dose is between 0.25-1.0 mg/kg/day.
  • Nephrotic syndrome: Initial dose of usually 1.5 mg/kg/day followed by down titration according to clinical need.
  • Bronchial asthma: On the basis of the potency ratio, the initial dose should be between 0.25-1.0 mg/kg on alternate days.
Deflazacort withdrawal: In patients who have received more than physiological doses of systemic corticosteroids (approximately 9 mg per day or equivalent) for greater than 3 weeks, withdrawal should not be abrupt. How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced.

Interaction

Deflazacort is metabolized in the liver. It is recommended to increase the maintenance dose of Deflazacort if drugs which are liver enzyme inducers are co-administered, e.g. rifampicin, rifabutin, carbamazepine, phenobarbitone, phenytoin, primidone and aminoglutethimide. For drugs which inhibit liver enzymes, (e.g. ketoconazole) it may be possible to reduce the maintenance dose of Deflazacort.

Contraindications

Hypersensitivity to or any of the ingredients. Patients receiving live virus immunization.

Side Effects

GI disturbances, musculoskeletal, endocrine, neuropsychiatric, ophthalmic, fluid and electrolyte disturbances; susceptible to infection, impaired healing, hypersensitivity, skin atrophy, striae, telangiectasia, acne, myocardial rupture following recent Ml, thromboembolism.

Pregnancy & Lactation

Pregnancy: Deflazacort does cross the placenta. However, when administered for prolonged periods or repeatedly during pregnancy, corticosteroids may increase the risk of intrauterine growth retardation. As with all drugs, corticosteroids should only be prescribed when the benefits to the mother and child outweigh the risks.

Nursing Mother: Corticosteroids are excreted in breast milk, although no data are available for Deflazacort. Doses of up to 50 mg daily of Deflazacort are unlikely to cause systemic effects in the infant. Infants of mothers taking higher doses than this may have a degree of adrenal suppression but the benefits of breastfeeding are likely to outweigh any theoretical risk.

Precautions & Warnings

The following clinical conditions require special caution and frequent patient monitoring is necessary-
  • Cardiac disease or congestive heart failure (except in the presence of active rheumatic carditis), hypertension, thromboembolic disorders. Glucocorticoids can cause salt and water retention and increased excretion of potassium. Dietary salt restriction and potassium supplementation may be necessary.
  • Gastritis or oesophagitis, diverticulitis, ulcerative colitis if there is the probability of impending perforation, abscess or pyogenic infections, fresh intestinal anastomosis, active or latent peptic ulcer.
  • Diabetes mellitus or family history, osteoporosis, myasthenia gravis, renal insufficiency.
  • Emotional instability or psychotic tendency, epilepsy.
  • Previous corticosteroid-induced myopathy.
  • Liver failure.
  • Hypothyroidism and cirrhosis, which may increase the glucocorticoid effect.
  • Ocular herpes simplex because of possible corneal perforation.

Storage Conditions

Store in a cool (below 25°C) and dry place, protected from light & moisture. Keep out of the reach of children.

Alternative brands of Deflazacort

Other brands with the same generic name, cheapest first.

See all 28 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.